For example, RPS15A was found to promote the progression of gastric carcinoma by activating the Akt pathway (13), and RPL11 expression was identified as a potential biomarker for predicting 5-fluorouracil (5-FU) sensitivity (14). This evidence concerns the gene AKT1 and gastric carcinoma.